Tiffany Garbutt, PhD

In an assessment of data from the International Network on Cancer registry, researchers determined that maternal 5-year survival for pregnant women with HL was comparable to that of their nonpregnant counterparts.

Researchers compared models for determining cumulative exposure of busulfan in adult and pediatric patients receiving the drug prior to allo-HCT.

A substudy of the PACIFIC trial sought to determine if low-grade pneumonitis associated with durvalumab should deter its use in patients with NSCLC.

Using a subset from the GeparOcto trial, researchers sought to determine if IV FCM was superior to physicians’ choice in treating chemotherapy-induced anemia in patients with breast cancer.

Researchers investigated the efficacy and safety of CHOP-like therapy for treatment-naïve patients with simultaneous diagnoses of NHL and HIV-positive.

Interviews with young cancer survivors revealed the 3 themes that define their concerns regarding the end of treatment.

Results of a novel program in which nurses fully provided services related to TIVADs, replacing use of PICC lines and improving patient quality of life and satisfaction.

A single-institution study is able to reproduce results of previous studies on the use of a scalp cooling system to prevent chemotherapy-induced hair loss in patients with breast cancer receiving anthracycline and/or taxane-based therapies.

Patient-specific, individualized coaching was found to provide needed support for patients with recurrent breast cancer.

Researchers sought to determine if practicing Kegel exercises, a common pelvic-floor exercise, could prevent urinary and fecal incontinence in patients with prostate cancer.